These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 353983)
21. Depo Provera: a review. Nash HA Contraception; 1975 Oct; 12(4):377-93. PubMed ID: 1104254 [No Abstract] [Full Text] [Related]
22. Long-term use of depot medroxy progesterone acetate as a contraceptive. el-Mahgoub S; Karim M; Ammar R Acta Obstet Gynecol Scand; 1972; 51(3):251-5. PubMed ID: 5072160 [No Abstract] [Full Text] [Related]
23. In utero medroxyprogesterone exposure after contraceptive failure. Brady JE; Brundage SC J Am Board Fam Pract; 1996; 9(4):285-8. PubMed ID: 8829079 [TBL] [Abstract][Full Text] [Related]
24. The use of sterile medroxyprogesterone acetate suspension as a contraceptive during a three-year period. Dodds GH Contraception; 1975 Jan; 11(1):15-23. PubMed ID: 1116356 [No Abstract] [Full Text] [Related]
25. Medroxyprogesterone acetate as a contraceptive. Hornemann B; Osler M Int J Fertil; 1972; 17(4):210-6. PubMed ID: 4362388 [No Abstract] [Full Text] [Related]
26. [Contraception with the 3-months injection]. Hauser GA Ther Umsch; 1972 May; 29(5):310-3. PubMed ID: 5064704 [No Abstract] [Full Text] [Related]
27. The use of Depo-Provera injections on a 6-monthly basis. Karstadt B S Afr Med J; 1976 Nov; 50(47):1887. PubMed ID: 1006452 [No Abstract] [Full Text] [Related]
28. Injectable contraception. International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1980 Dec; 14(6):1-3. PubMed ID: 12310087 [TBL] [Abstract][Full Text] [Related]
29. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues? Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125 [TBL] [Abstract][Full Text] [Related]
31. Depo provera in perspective. McGoldrick IA P N G Med J; 1981 Dec; 24(4):274-9. PubMed ID: 6461984 [TBL] [Abstract][Full Text] [Related]
32. Acceptability of injectable contraception in the philippines. Apelo RA; De la Cruz JR; Lopez FC IPPF Med Bull; 1974 Apr; 8(2):1-2. PubMed ID: 4619799 [No Abstract] [Full Text] [Related]
33. Long-term contraception with Depo-Provera: a clinical evaluation. Mukherjea M; Mukherjee P; Biswas R Int J Fertil; 1980; 25(2):122-6. PubMed ID: 6117526 [TBL] [Abstract][Full Text] [Related]
35. Depo-Provera use in Sri Lanka: acceptor characteristics, continuation and side effects. Basnayake S; Thapa S Adv Contracept Deliv Syst; 1986 Oct; 2(4):307-21. PubMed ID: 12341188 [TBL] [Abstract][Full Text] [Related]
36. Medroxyprogesterone acetate (MPA) for contraception. Sajadi HE; Borazjani G; Ardekany MS Int J Fertil; 1972; 17(4):217-20. PubMed ID: 4362389 [No Abstract] [Full Text] [Related]